According to the latest report by IMARC Group, titled “Global Pediatric Interventional Cardiology Market Size, Share, Industry Trends, Growth, Opportunity and Forecast 2022-2027“, the global pediatric interventional cardiology market reached a value of US$ 2.28 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 3.46 Billion by 2027, exhibiting a CAGR of 6.80% during 2022-2027.
Pediatric interventional cardiology is a sub-specialty of cardiology that incorporates intravascular catheter-based techniques with fluoroscopy to treat cardiac disorders. Certified interventional cardiologists perform it in cases of coronary artery, valvular, and congenital cardiac diseases in infants, children and adolescents up to the age of 18 years. It includes balloon angioplasty, coil occlusion, stent implantation, and aortic valve stenosis. Nowadays, it is increasingly performed across clinical testing laboratories, research institutes, cardiac centers, and hospitals.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/pediatric-interventional-cardiology-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Pediatric Interventional Cardiology Market Trends and Drivers:
The global market is primarily driven by the rising instances of congenital disorders and heart diseases among children. In addition to this, the growing need for minimally invasive (MI) producers that reduce scarring, lower the risk of infection, and offer short postoperative recovery time for patients, is fueling the market growth.
Pediatric interventional cardiology procedure is generally considered to be minimally invasive as it does not require multiple instruments or large incisions in the body. Moreover, key manufacturers are introducing novel and efficient interventional cardiology devices, such as catheters, bioabsorbable stents, guidewires and atherectomy devices, to create a positive outlook for the market.
Furthermore, the increasing healthcare expenditure coupled with extensive research and development (R&D) activities is also expected to propel the market in the upcoming years.
Inquire Before Buying : https://www.imarcgroup.com/request?type=report&id=5043&flag=F
Global Pediatric Interventional Cardiology Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, NuMED Inc., Siemens Healthineers AG, Terumo Corporation and W. L. Gore & Associates Inc.
The report has segmented the market on the basis of region, device type, procedure and end use.
Breakup by Device Type:
- Closure Devices
- Transcatheter Heart Valves
- Atherectomy Devices
Breakup by Procedure:
- Catheter-Based Valve Implantation
- Congenital Heart Defect Correction
- Coronary Thrombectomy
Market Breakup by End Use:
- Clinical Testing Laboratories
- Cardiac Centers
- Pediatric Clinics
- Research Institutions
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/pediatric-interventional-cardiology-market
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800